Ancora Advisors, LLC Bristol Myers Squibb CO Transaction History

Ancora Advisors, LLC

$4.06 Billion
Q3 2024

A detailed history of Ancora Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ancora Advisors, LLC holds 29,127 shares of BMY stock, worth $1.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

29,127

Previous 38,316 23.98%

Holding current value

$1.7 Million

Previous $1.59 Million 5.28%

% of portfolio

0.04%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $364,435 - $475,530	-9,189 Reduced 23.98%	29,127 $1.51 Million
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $105,535 - $138,939	-2,622 Reduced 6.4%	38,316 $1.59 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $175,318 - $198,777	3,654 Added 9.8%	40,938 $2.22 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $55,364 - $66,064	1,142 Added 3.16%	37,284 $1.91 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $54,358 - $60,781	-939 Reduced 2.53%	36,142 $2.1 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $25,229 - $28,013	396 Added 1.08%	37,081 $2.37 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $64,264 - $72,890	-978 Reduced 2.6%	36,685 $2.54 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $200,646 - $237,593	2,930 Added 8.44%	37,663 $2.71 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $232 - $137,697	-1,792 Reduced 4.91%	34,733 $2.47 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $49,817 - $54,866	686 Added 1.91%	36,525 $2.81 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $195,014 - $233,839	-3,172 Reduced 8.13%	35,839 $2.62 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $164,459 - $197,201	2,675 Added 7.36%	39,011 $2.46 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $47,462 - $55,330	-885 Reduced 2.38%	36,336 $2.27 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $27,040 - $31,674	-457 Reduced 1.21%	37,221 $2.2 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $82,526 - $89,870	-1,333 Reduced 3.42%	37,678 $2.52 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $23,083 - $25,961	-389 Reduced 0.99%	39,011 $2.46 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $68,017 - $77,076	-1,178 Reduced 2.9%	39,400 $2.44 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $26,417 - $29,274	460 Added 1.15%	40,578 $2.45 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $874,653 - $1.02 Million	-15,955 Reduced 28.45%	40,118 $2.36 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $324 - $472	7 Added 0.01%	56,073 $3.13 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $485,358 - $633,105	9,863 Added 21.35%	56,066 $3.6 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $11,505 - $13,640	-269 Reduced 0.58%	46,203 $2.34 Million
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $396,716 - $438,681	8,891 Added 23.66%	46,472 $2.11 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $4.4 Million - $5.25 Million	-97,596 Reduced 72.2%	37,581 $1.79 Million
Q4 2018 Feb 15, 2019	SELL	$48.76 - $63.23 $722,330 - $936,689	-14,814 Reduced 9.88%	135,177 $7.03 Million
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $1.78 Million - $2.01 Million	32,267 Added 27.41%	149,991 $9.31 Million
Q2 2018 Aug 10, 2018	BUY	$50.53 - $62.98 $112,025 - $139,626	2,217 Added 1.92%	117,724 $6.52 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $319,433 - $367,732	5,331 Added 4.84%	115,507 $7.31 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $161,178 - $175,726	2,689 Added 2.5%	110,176 $6.75 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $5.94 Million - $6.85 Million	107,487	107,487 $6.85 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Account

Ancora Advisors, LLC Bristol Myers Squibb CO Transaction History